The Keralam government has constituted an expert committee to comprehensively review the NoRKA Care health and accident insurance scheme for non-resident Keralites and their families, introduced by the previous Left Democratic Front (LDF) government. The panel will examine complaints over the steep increase in premiums during the scheme's second phase and recommend measures to ensure its long-term financial sustainability.

Premiums rose sharply for the second phase of the scheme, launched in collaboration with a leading public sector insurance company, soon after the new government assumed office. For instance, the premium for a family floater policy with a coverage of ₹5 lakh increased from ₹13,411 to between ₹35,664 and ₹77,773, placing a considerable financial burden on ordinary expatriates, many of whom earn modest wages, as well as senior citizens who have returned to Keralam.

During the first phase, around 1.62 lakh expatriate families from 138 countries enrolled in the NoRKA Care and NoRKA Care Plus schemes. As of July 31, 2026, ₹227 crore had been disbursed to 31,660 policyholders towards claims, with the claim settlement rate standing at 99.38%. The scheme offers cashless treatment at around 24,000 hospitals across the country, including more than 688 hospitals in Keralam.

Rajesh Madhavan, chief executive officer of NoRKA-Roots, the field agency of the Department of Non-Resident Keralites Affairs (NoRKA), and a member-convener of the expert committee, said that the panel will examine the premium structure, product design, affordability and long-term sustainability of the scheme. Its terms of reference include reviewing the existing premium structure, particularly the substantial increase for beneficiaries in the 41–70 age group, and exploring the possibility of rationalising rates across age categories, while safeguarding beneficiaries' interests. The committee, headed by the Additional Chief Secretary, Finance department, has been asked to submit its recommendations within one month of its constitution.